Emerging role of competing endogenous RNA in lung cancer drug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging role of competing endogenous RNA in lung cancer drug resistance

Published:2023-12-20 Issue: Volume: Page:1-20
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Wu Shijie¹,Luo Ting¹,Lei Xiaoyong¹²,Yang Xiaoyan¹²

Affiliation:

1. School of Pharmaceutical Science, Hengyang Medical College, University of South China, Hengyang, People’s Republic of China

2. Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, University of South China, Hengyang, People’s Republic of China

Funder

Hengyang City Science and Technology Planning Project

Scientific Research Project of Hunan Provincial Health Commission

Scientific Research Project of Hunan Provincial Education Department

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2023.2294582

Reference150 articles.

1. A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay

2. Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis

3. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1

4. Lung cancer

5. Lung cancer: current therapies and new targeted treatments

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP